219 related articles for article (PubMed ID: 2531219)
41. The kidney: imaging with Tc-99m mercaptoacetyltriglycine, a technetium-labeled analog of iodohippurate.
Russell CD; Thorstad BL; Stutzman ME; Yester MV; Fowler D; Dubovsky EV
Radiology; 1989 Aug; 172(2):427-30. PubMed ID: 2526350
[TBL] [Abstract][Full Text] [Related]
42. Complexes of technetium-99m with tetrapeptides containing one alanyl and three glycyl moieties.
Vanbilloen HP; De Roo MJ; Verbruggen AM
Eur J Nucl Med; 1996 Jan; 23(1):40-8. PubMed ID: 8586100
[TBL] [Abstract][Full Text] [Related]
43. Can technetium-99m-mercaptoacetyltriglycine replace technetium-99m-dimercaptosuccinic acid in the exclusion of a focal renal defect?
Gordon I; Anderson PJ; Lythgoe MF; Orton M
J Nucl Med; 1992 Dec; 33(12):2090-3. PubMed ID: 1334134
[TBL] [Abstract][Full Text] [Related]
44. Evaluation of renal function from 99mTc-MAG3 renography without blood sampling.
Inoue Y; Ohtake T; Yokoyama I; Yoshikawa K; Asai S; Ohtomo K
J Nucl Med; 1999 May; 40(5):793-8. PubMed ID: 10319752
[TBL] [Abstract][Full Text] [Related]
45. Technetium-99m-EC and other potential new agents in renal nuclear medicine.
Moran JK
Semin Nucl Med; 1999 Apr; 29(2):91-101. PubMed ID: 10321823
[TBL] [Abstract][Full Text] [Related]
46. Comparison of technetium-99m MAG3 with iodine-131 hippuran by a simultaneous dual channel technique.
Russell CD; Thorstad B; Yester MV; Stutzman M; Baker T; Dubovsky EV
J Nucl Med; 1988 Jul; 29(7):1189-93. PubMed ID: 2969040
[TBL] [Abstract][Full Text] [Related]
47. 99mTc-MAG3: review of pharmacokinetics, clinical application to renal diseases and quantification of renal function.
Itoh K
Ann Nucl Med; 2001 Jun; 15(3):179-90. PubMed ID: 11545186
[TBL] [Abstract][Full Text] [Related]
48. Comparative study of the kinetics of the renal tracers 99Tcm-MAG3 and 131I-hippuran.
Pavía J; Ros D; Piera C; Pavía A; Bassa P; Giralt E; Setoain J
Nucl Med Commun; 1991 Jun; 12(6):529-37. PubMed ID: 1830943
[TBL] [Abstract][Full Text] [Related]
49. Diuresis renography. A simultaneous comparison between 131I-hippuran and 99Tcm-MAG3.
Hvid-Jacobsen K; Thomsen HS; Nielsen SL
Acta Radiol; 1990 Jan; 31(1):83-6. PubMed ID: 2140270
[TBL] [Abstract][Full Text] [Related]
50. [Parametric representation of kidney function using 99mTc-mercaptoacetyltriglycine (MAG3)].
Szabó Z; Kutkuhn B; Georgescu G; Mecklenbeck W; Suatmadji A; Vosberg H
Nuklearmedizin; 1989 Jun; 28(3):73-83. PubMed ID: 2525703
[TBL] [Abstract][Full Text] [Related]
51. 99mTc-MAG3: dynamic studies in patients with renal disease.
Schaap GH; Alferink TH; de Jong RB; Oe PL; Roos JC; Donker AJ
Eur J Nucl Med; 1988; 14(1):28-31. PubMed ID: 2968259
[TBL] [Abstract][Full Text] [Related]
52. Will 99mTc-MAG3 replace 131I-OIH and 99mTc-DTPA in the follow-up of renal transplants?
Dubovsky EV; Russell CD; Yester MV; Thorstad BL; Ryan JP
Contrib Nephrol; 1990; 79():118-22. PubMed ID: 2146081
[No Abstract] [Full Text] [Related]
53. Simultaneous estimation of glomerular filtration rate and renal plasma flow.
Fresco GF; DiGiorgio F; Curti GL
J Nucl Med; 1995 Sep; 36(9):1701-6. PubMed ID: 7658234
[TBL] [Abstract][Full Text] [Related]
54. Sequential Tc 99m mercaptoacetyl-triglycine (MAG3) renography as an evaluator of early renal transplant function.
Carmody E; Greene A; Brennan P; Donohue J; Carmody M; Keeling F
Clin Transplant; 1993 Jun; 7(3):245-9. PubMed ID: 10148844
[TBL] [Abstract][Full Text] [Related]
55. [Usefulness of renal dynamic function study with 99mTc-MAG3 (mercaptoacetylglycylglycylglycine)].
Shirakawa S; Tamaki N; Torizuka T; Fujita T; Yano S; Tsuchimochi S; Yonekura Y; Konishi J; Terai A
Kaku Igaku; 1994 Aug; 31(8):977-83. PubMed ID: 7933686
[TBL] [Abstract][Full Text] [Related]
56. The difference in clearance between kit-prepared technetium-99m-MAG3 and radioiodinated hippuric acid.
Bubeck B; Brandau W
J Nucl Med; 1991 Aug; 32(8):1642-4. PubMed ID: 1831230
[No Abstract] [Full Text] [Related]
57. Effect of renal maturation on the clearance of technetium-99m mercaptoacetyltriglycine.
Lythgoe MF; Gordon I; Anderson PJ
Eur J Nucl Med; 1994 Dec; 21(12):1333-7. PubMed ID: 7875172
[TBL] [Abstract][Full Text] [Related]
58. 99mTc-mercaptoacetyltriglycine camera-based measurement of renal clearance: should the result be normalized for body surface area?
Klingensmith WC
J Nucl Med Technol; 2013 Dec; 41(4):279-82. PubMed ID: 24167023
[TBL] [Abstract][Full Text] [Related]
59. First experience in healthy volunteers with technetium-99m L,L-ethylenedicysteine, a new renal imaging agent.
Van Nerom CG; Bormans GM; De Roo MJ; Verbruggen AM
Eur J Nucl Med; 1993 Sep; 20(9):738-46. PubMed ID: 8223766
[TBL] [Abstract][Full Text] [Related]
60. [Comparison of single sample methods for determination of plasma clearance using 99mTc-MAG3].
Itoh K; Tsukamoto E; Mochizuki T; Kanegae K; Katoh C; Tamaki N
Kaku Igaku; 1998 Oct; 35(8):689-95. PubMed ID: 9847510
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
